In. Hampson et al., IDENTIFICATION OF A SERPIN SPECIFICALLY EXPRESSED IN MULTIPOTENT AND BIPOTENT HEMATOPOIETIC PROGENITOR CELLS AND IN ACTIVATED T-CELLS, Blood, 89(1), 1997, pp. 108-118
We have identified a gene that has a high level of mRNA expression in
undifferentiated, multipotential hematopoietic cells (FDCP-Mix) and th
at downregulates both transcript and protein, as these cells are induc
ed to differentiate into mature myeloid cells. Sequence analysis of th
is gene has identified it as a serine protease inhibitor EB22/3 (serpi
n 2A). Constitutive expression of serpin 2A in FDCP-Mix cells was asso
ciated with an increase In the clonogenic potential of the cells and w
ith a delay in the appearance of fully mature entiation when compared
with control cells, Serpin 2A was also found to be expressed in bone m
arrow-derived bipotent granulocyte macrophage progenitor cells (GM-col
ony forming cell [CFC]), but not in erythrocyte progenitor cells from
day 15 fetal liver. Expression of serpin 2A also showed a marked up re
gulation during the activation of cytotoxic suppressor CD8(+) T cells,
with a clear lag between the appearance of transcript and detection o
f protein. (C) 1997 by The American Society of Hematology.